EN
HI

AKUMS DRUGS AND PHARMA L Share price

AKUMS

HealthcareMid

512.65

7.20 (-1.39%)
NSE
BSE
Last updated on 6 May, 2025 | 15:41 IST
BUYSELL
Today's High

503.85

Today's Low

518.20

52 Week Low

1175.90

52 Week High

1175.90

The current prices are delayed, login to your account for live prices

Akums Drugs & Pharmaceuticals Chart

AKUMS DRUGS AND PHARMA L Share Key Metrics

Volume
2.16 L
Market Cap
8068.80 CR
LTQ@LTP
64@512.65
ATP
512.16
Var Margin
1977
Circuit Range
467.9-571.8
Delivery %
58.68
Value
11.07 CR
ASM/GSM
No
Market Lot
1

AKUMS DRUGS AND PHARMA L Futures & Options

Data Not Found

AKUMS DRUGS AND PHARMA L Corporate Actions

DateAgenda
2025-02-06Quarterly Results
DateEvent TypeAgenda
2025-02-06Board MeetingQuarterly Results

AKUMS DRUGS AND PHARMA L News

No Data Found

About AKUMS DRUGS AND PHARMA L

NSE : 24715  
BSE : 544222  
ISIN : INE09XN01023  

Our Company was incorporated as a public limited company under the Companies Act 1956 as ‘Akums Drugs and Pharmaceuticals Limited’ pursuant to a certificate of incorporation dated April 19 2004 issued by the RoC. Our Company received a certificate for commencement of business issued by the RoC dated May 13 2004.Major Events and Milestones:2004-Incorporation of the Company-Established first plant for oral dosage commissioned at 19 20 21 sector 6A Haridwar Uttarakhand2007-Established dedicated manufacturing site for oral liquid dosage at 22 Sector 6A Sidcul Haridwar Uttarakhand and sterile products at 2345 Sector 6B SIDCUL Haridwar Uttarakhand2009-Incorporated Maxcure Nutravedics Limited to venture into nutraceuticals2010-Dedicated a facility for hormones at 48 Sector 6A SIDCUL Haridwar Uttarakhand-Dedicated a facility for cosmetics and dermatology at 47 Sector 6A SIDCUL Haridwar Uttarakhand-Incorporated Akumentis Healthcare Limited to venture into branded formulations2011-Innovated bi-layered sustained release tablets for the first time2012-Acquired Pure and Cure Healthcare Private Limited to expand capacity and capabilities2013-Innovated tablet-in-tablet sustained release tablets for the first time-Acquired Malik Lifesciences Private Limited manufacturing sites to expand capacity and capabilities-Expanded into the African market2015-Expanded into the Asian market-Established research and development laboratory in Mumbai Maharashtra to venture into regulated market2016-Maxcure Nutravedics Limited received US-NSF certification2019-Investment by Ruby QC Investment Holdings Pte. Ltd. in our Company to become a minority shareholder2021-Acquired Parabolic Drugs to form Akums Lifesciences Limited and ventured into APIs-Acquisition of a facility at Kotdwar Uttarakhand by Akums Healthcare Limited2022-Plant at 19 20 21 Sector 6A SIDCUL Haridwar Uttarakhand and plant at 2 3 45 Sector 6B SIDCUL Haridwar Uttarakhand accredited European Union-Good Manufacturing Practices qualifying for exports to European markets-Acquisition of a facility in Haridwar Uttarakhand by Akums Healthcare Limited and a facility in Baddi Himachal Pradesh by Pure and Cure Healthcare Private Limited2023-Acquisition of another facility in Baddi Himachal Pradesh by Pure and Cure Healthcare Private Limited-Merger of Akums Lifesciences Limited with Pure and Cure Healthcare Private Limited

AKUMS DRUGS AND PHARMA L Management

NamePosition
Mr. Sanjeev Jain Managing Director
Mr. Sandeep Jain Managing Director
Mr. Sanjay Sinha Whole Time Director
Mr. Sunil Kumar Thakur Non Exe. & Nominee Director
Ms. Matangi Gowrishankar Independent Director
Read More

AKUMS DRUGS AND PHARMA L FAQs

The Buying Price of AKUMS DRUGS AND PHARMA L share is 512.65 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy AKUMS DRUGS AND PHARMA L share to your Choice trading account, or open a Choice Demat account, then add funds, search the company name, select your order type, and place your trade.

The Price-to-earnings (P/E) ratio of AKUMS DRUGS AND PHARMA L shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio AKUMS DRUGS AND PHARMA L shares is 3.59. Useful to assess the stock's value relative to its book value.

To assess AKUMS DRUGS AND PHARMA L’s valuation compare Sector P/E, P/B which are 34.16 & 4.86 with sector averages, along with growth rates and financial metrics.

The Market Cap of AKUMS DRUGS AND PHARMA L is 8068.80 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of AKUMS DRUGS AND PHARMA L share price is 1175.90 & 405.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.